NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $512,397 | -14.4% | 70,773 | -12.2% | 0.00% | -20.0% |
| Q2 2023 | $598,873 | -0.4% | 80,602 | -7.1% | 0.01% | 0.0% |
| Q1 2023 | $601,552 | +1.2% | 86,804 | +50.1% | 0.01% | 0.0% |
| Q4 2022 | $594,462 | -18.7% | 57,827 | +43.9% | 0.01% | -28.6% |
| Q3 2022 | $731,000 | -62.9% | 40,182 | +4.9% | 0.01% | -56.2% |
| Q2 2022 | $1,970,000 | -7.0% | 38,299 | +33.1% | 0.02% | +23.1% |
| Q1 2022 | $2,119,000 | -28.1% | 28,777 | +39.7% | 0.01% | -13.3% |
| Q4 2021 | $2,947,000 | -16.6% | 20,600 | +20.8% | 0.02% | -28.6% |
| Q3 2021 | $3,535,000 | -17.9% | 17,052 | -15.9% | 0.02% | -16.0% |
| Q2 2021 | $4,304,000 | +26.5% | 20,274 | +8.0% | 0.02% | +13.6% |
| Q1 2021 | $3,403,000 | +25.5% | 18,768 | -22.8% | 0.02% | +29.4% |
| Q4 2020 | $2,712,000 | – | 24,324 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |